Treatment for leukemia and idiopathic aplastic anemia

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/496 (2006.01) A61K 31/343 (2006.01) A61K 31/4375 (2006.01) A61K 31/438 (2006.01) A61K 31/4709 (2006.01) A61K 31/5383 (2006.01) A61P 31/04 (2006.01) A61P 35/02 (2006.01)

Patent

CA 2737493

A process for treating a patient with leukemia or an aplastic anemia having cells with inclusions that stain with anti-E. canis antibodies or antibodies to other Ehrlichia or Anaplasma is disclosed. That process comprises administering to the patient (i) an antibacterial amount of a rifamycin, (ii) an antibacterial amount of a quinolone, or a mixture of (i) and (ii).

Cette invention concerne un procédé de traitement dun patient atteint de leucémie ou danémie aplasique ayant des cellules à inclusions colorées avec des anticorps anti-E. canis ou des anticorps dirigés contre dautres pathogènes du genre Ehrlichia ou Anaplasma. Le procédé comprend ladministration au patient (i) dune quantité antibactérienne dune rifampicine, (ii) dune quantité antibactérienne dune quinolone, ou dun mélange de (i) et (ii).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment for leukemia and idiopathic aplastic anemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment for leukemia and idiopathic aplastic anemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for leukemia and idiopathic aplastic anemia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2069796

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.